Table 3.
Treatment-related adverse events.
HEC study | MEC study | |||||||
---|---|---|---|---|---|---|---|---|
S group | (n = 28) | R group | (n = 29) | S group | (n = 30) | R group | (n = 32) | |
Grade 1/2 | Grade 3/4 | Grade 1/2 | Grade 3/4 | Grade 1/2 | Grade 3/4 | Grade 1/2 | Grade 3/4 | |
Constipation | 13 (46.4%) | 0 | 13 (44.8%) | 0 | 6 (20.0%) | 1 (3.3%) | 5 (15.6%) | 0 |
Diarrhea | 1 (3.6%) | 0 | 4 (13.8%) | 1 (3.4%) | 4 (13.3%) | 0 | 1 (3.1%) | 0 |
Hiccups | 4 (14.3%) | 0 | 5 (17.2%) | 0 | 0 | 0 | 3 (9.4%) | 0 |